Literature DB >> 2173458

Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by beta-adrenoceptor agonists.

R G Van Amsterdam1, H Meurs, R E Ten Berge, N C Veninga, F Brouwer, J Zaagsma.   

Abstract

The aim of the present investigation was to study in human bronchial smooth muscle (1) the relationship between methacholine and histamine-induced inositol phosphate (IP) production and contraction, (2) the influence of increasing concentrations of methacholine and histamine on the relaxation (pD2 and Emax) by isoproterenol (functional antagonism), and (3) the relation between IP production by methacholine and histamine and the changes of pD2 and Emax values of isoproterenol-induced relaxation. Methacholine and histamine were full agonists in contracting human bronchial smooth muscle, with pD2 values of 6.01 +/- 0.18 and 6.07 +/- 0.04, respectively. With IP production, however, pD2 values of 4.90 +/- 0.06 for methacholine and 5.15 +/- 0.16 for histamine were obtained, indicating a considerable reserve of PI metabolism for contraction. With increasing concentrations of histamine and methacholine (to 1 and 0.1 mM, respectively), subsequently performed dose-relaxation curves with isoproterenol showed decreasing values of pD2 (from 8.25 +/- 0.20 to 7.28 +/- 0.28) and Emax (from 100% to 56.7 +/- 12.4%). No differences were observed between methacholine and histamine in this respect. A significant correlation was found between IP production induced by the various concentrations of methacholine and histamine and the reduction of isoproterenol pD2 and Emax values. The results strongly suggest that PI metabolism may play an important role in the reduced efficacy of beta-adrenoceptor agonists to induce bronchodilation during active and severe asthma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173458     DOI: 10.1164/ajrccm/142.5.1124

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms.

Authors:  Gary P Anderson
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

2.  InsP3, but not novel Ca2+ releasers, contributes to agonist-initiated contraction in rabbit airway smooth muscle.

Authors:  K Iizuka; A Yoshii; K Dobashi; T Horie; M Mori; T Nakazawa
Journal:  J Physiol       Date:  1998-09-15       Impact factor: 5.182

3.  Mechanical and biochemical responses to endothelin-1 and endothelin-3 in bovine bronchial smooth muscle.

Authors:  J E Nally; R McCall; L C Young; M J Wakelam; N C Thomson; J C McGrath
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  Effects of muscarinic M2 and M3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro.

Authors:  N Watson; R M Eglen
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

5.  Modulation of agonist-induced phosphoinositide metabolism, Ca2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms.

Authors:  B H Hoiting; H Meurs; M Schuiling; R Kuipers; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors.

Authors:  J de Boer; A J Philpott; R G van Amsterdam; M Shahid; J Zaagsma; C D Nicholson
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.

Authors:  A F Roffel; H Meurs; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Effects of beta 2-adrenoceptor agonists on anti-IgE-induced contraction and smooth muscle reactivity in human airways.

Authors:  I Gorenne; C Labat; X Norel; V De Montpreville; M C Guillet; I Cavero; C Brink
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

Review 9.  The evidence on tiotropium bromide in asthma: from the rationale to the bedside.

Authors:  Dejan Radovanovic; Pierachille Santus; Francesco Blasi; Marco Mantero
Journal:  Multidiscip Respir Med       Date:  2017-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.